Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Late-onset Invasive Infection”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableUnknownNCT04653948
What this trial is testing

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Who this might be right for
Group B Streptococcus Carrier in ChildbirthGroup B Streptococcal Infection, Late-OnsetGroup B Streptococcal Infection, Early-Onset+2 more
St George's, University of London 3,423
Not applicableNot Yet RecruitingNCT06896526
What this trial is testing

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Who this might be right for
Invasive Group B Streptococcus DiseaseGroup B StreptococcusGroup B Streptococcal Infection+3 more
Precia Group 10,000
Not applicableStudy completedNCT01727609
What this trial is testing

Speed of Increasing Milk Feeds Trial

Who this might be right for
Premature BirthLate-onset Invasive InfectionNecrotizing Enterocolitis
University of Oxford 2,804
Not applicableStudy completedNCT01406093
What this trial is testing

Early- and Late-onset Candidemia

Who this might be right for
Candidemia
Giovanni Di Perri 400
Not applicableStudy completedNCT00113191
What this trial is testing

Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Who this might be right for
Nosocomial InfectionsSepsisStaphylococcal Infections+1 more
Bristol-Myers Squibb 2,000